•HR 1200 SC4
(e) ADVISORY COMMITTEE ON MENTAL HEALTH AND
SUBSTANCE ABUSE TREATMENT SERVICES.—
(1) IN GENERAL.—The Board shall appoint a
standing Advisory Committee on Mental Health and
Substance Abuse Treatment Services to advise it
with respect to the manner in which the benefits
under this Act for mental health services and sub-
stance abuse treatment services should be modified
to best meet the objectives of this Act.
(2) MEMBERSHIP.—The membership of the
committee shall include individuals (in such number
as the Board may determine) with expertise in
health care economics, who are representative of the
multi-disciplinary range of providers of such serv-
ices, who are consumers of such services, and who
represent advocacy groups representing consumers
of such services.
(3) RESPONSIBILITIES.—The committee shall—
(A) study changes in the utilization pat-
terns and costs which accompany the provision
of mental health services and substance abuse
treatment services;
(B) study and make recommendations on
any changes that may be advisable in the utili-
•HR 1200 SC4
zation review thresholds specified in section
204(b)(2)(A);
(C) make recommendations on ways to cre-
ate a continuum of care and encourage the pro-
vision of care in the least restrictive appropriate
setting;
(D) develop a standard set of practices for
care coordination services, including—
(i) the range of care coordination
services that should be offered for a spe-
cific target population,
(ii) the organizational structure in
which care coordination services should be
based,
(iii) the minimum training require-
ments for care coordinators, and
(iv) the standards for the clinical ne-
cessity of care coordination services,
and study (and make recommendations con-
cerning) peer care coordination services; and
(E) report any initial recommendations to
the Board by January 1, 1995.
(4) ROLE OF SUBSTANCE ABUSE AND MENTAL
HEALTH
SERVICES
ADMINISTRATION.—The Board
shall consult with the Administrator of the Sub-
•HR 1200 SC4
stance Abuse and Mental Health Services Adminis-
tration in the appointment of members to, and
operation of, the committee.
(f) 
ADVISORY
COMMITTEE
ON
PRESCRIPTION
DRUGS.—
(1) IN GENERAL.—The Board shall appoint a
standing Advisory Committee on Prescription Drugs
to advise it with respect to the list of approved pre-
scription drugs and biologicals under section
616(a)(1) and other matters relating to the coverage
of prescription drugs under this Act.
(2) MEMBERSHIP.—
(A) IN GENERAL.—The membership of the
committee shall include individuals (in such
number as the Board may determine) with ex-
pertise in appropriate utilization of prescription
and nonprescription drug and biological thera-
pies and of the relative safety and efficacy of
prescription drugs and biologicals.
(B) AREAS OF EXPERTISE.—A majority of
the members of the committee shall be physi-
cians. Members of the committee shall include
at least a dentist, a nurse, and a pharmacist,
and individuals with special knowledge or exper-
tise in at least the following areas: geriatric, ob-
•HR 1200 SC4
stetric, pediatric, psychiatric, and neurological
problems associated with drug therapies; clini-
cal pharmacology; pharmacoepidemiology; and
comparative clinical trials of drugs (including
statisticians and biopharmaceutic specialists).
(C) CONFLICT
OF
INTEREST
PROHIBI-
TION.—No individual who is an employee of a
manufacturer of a drug or biological or who
otherwise has a material financial interest di-
rectly or indirectly with respect to such a manu-
facturer, or who has an immediate family mem-
ber (as defined by the Board) who is such an
employee or has such an interest, shall serve as
a member of the committee.
(3) RESPONSIBILITIES.—The committee shall—
(A) continuously review scientific and med-
ical information pertaining to the relative safety
and efficacy, and the comparability, of prescrip-
tion drugs and biologicals approved for market-
ing in the United States; and
(B) recommend drug use classifications
and identify, within such a classification, drugs
that are therapeutic alternates for a given indi-
cation and indications for which particular
drugs are superior based on safety and efficacy.
•HR 1200 SC4
The committee is not authorized to engage in drug
price negotiations nor define acceptable costs for any
product.
(4) CONSUMER INPUT.—In conducting its ac-
tivities, the committee shall solicit advice and com-
ments from a panel of consumer advocates.
(g) TEMPORARY COMMITTEES.—The Board is au-
thorized to appoint such temporary professional and tech-
nical committees as it deems necessary to advise it on spe-
cial problems not encompassed in the assignments of
standing committees appointed under this section or to
supplement the advice of standing committees.
(h) REPORTING.—Committees appointed under this
section shall report from time to time (but not less often
than biannually) to the Board, and copies of their reports
shall be transmitted by the Board to the American Health
Security Advisory Council and be made readily available
to the public.
(i) COMPENSATION.—All members of the committees
established under this section shall be reimbursed by the
Board for travel and per diem in lieu of subsistence ex-
penses during the performance of duties of the Board in
accordance with subchapter I of chapter 57 of title 5,
United States Code.
•HR 1200 SC4
(j) ADVICE FROM PROSPECTIVE PAYMENT ASSESS-
MENT COMMISSION, PRACTITIONER PAYMENT REVIEW
COMMISSION, ETC.—For provisions relating to role of cer-
tain commissions in reviewing payment rates, see section
620.
SEC. 404. AMERICAN HEALTH SECURITY QUALITY COUNCIL.
(a) ESTABLISHMENT.—There is hereby established
an American Health Security Quality Council.
(b) APPOINTMENT AND TERMS OF MEMBERS.—
(1) IN GENERAL.—The Council shall be com-
posed of 10 members appointed by the President.
The President shall first appoint individuals on a
timely basis so as to provide for the operation of the
Council by not later than January 1, 1994.
(2) SELECTION OF MEMBERS.—Each member
of the Council shall be a member of a health profes-
sion. Six members of the Council shall be physicians.
Individuals shall be appointed to the Council on the
basis of national reputations for clinical and aca-
demic excellence.
(3) TERMS
OF
MEMBERS.—Individuals ap-
pointed to the Council shall serve for a term of 5
years, except that the terms of 4 of the individuals
initially appointed shall be, as designated by the